Researchers identify new therapeutic for patients with a rare autoimmune disease EGPA

An international team, including researchers from McMaster University and St. Joseph's Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA).

Related Keywords

Canada ,Canadian ,Freddy Hargreave ,Nader Khalidi ,Parameswaran Nair ,Firestone Institute For Respiratory Health At St ,Mcmaster University ,Mcmaster Department Of Medicine ,Joe Firestone Institute For Respiratory Health ,Firestone Institute At St ,Astrazeneca ,Healthcare Hamilton ,New England Journal ,Firestone Institute ,Churg Strauss Syndrome ,Respiratory Health ,Autoimmune Disease ,Asthma ,Flood ,Clinical Trial ,Drugs ,Efficacy ,Eosinophil ,Granulomatosis With Polyangiitis ,Healthcare ,Lungs ,Medicine ,Prednisone ,Rare Disease ,Research ,Espiratory ,